Cyclin D1 in astrocytic tumours: an immunohistochemical study.
Forty-eight astrocytic tumours were stained immunohistochemically with antibodies to the cell cycle-regulating protein, cyclin D1, and to the proliferation marker MIB1 (Ki-67) using formalin fixed paraffin embedded tissue and a microwave antigen retrieval system. Cases were classified by the WHO system (1993). The labelling indices (LI) for both antibodies were compared with each other and with the tumour type. The mean labelling indices for both antibodies increased with the degree of malignancy, and a significant difference was seen between the pilocytic astrocytoma and diffuse astrocytoma together vs anaplastic astrocytoma and glioblastoma together. However, within each tumour type there was considerable variation in the labelling indices and a clear cut off value could not be demonstrated. There was a strong positive correlation between labelling indices for cyclin D1 and MIB1 in diffuse astrocytoma, but this correlation broke down increasingly in anaplastic astrocytoma and glioblastoma. There was poor correlation between cyclin D1 and MIB1 in pilocytic astrocytoma, a feature which appeared to separate them from the diffuse astrocytoma. Average labelling indices for cyclin D1 were higher than those of MIB1, which suggests that cyclin D1 positive cells represent a pool of cells from which proliferation and hence MIB1 expression can take place. In conclusion, cyclin D1 is overexpressed in astrocytic tumours, more so with increasing grade of malignancy and in a way which approximately correlates with MIB1 expression.
Chakrabarty
A
A
Neuropathology Laboratory, General Infirmary at Leeds, University of Leeds, UK.
Bridges
L R
LR
Gray
S
S
D000951:Antigens, Neoplasm / Q000276:immunology / Q000378:metabolism; D001254:Astrocytoma / Q000378:metabolism* / Q000473:pathology / Q000648:ultrastructure; D001932:Brain Neoplasms / Q000378:metabolism* / Q000473:pathology / Q000648:ultrastructure; D002467:Cell Nucleus / Q000378:metabolism; D019938:Cyclin D1; D016213:Cyclins / Q000378:metabolism*; D005909:Glioblastoma / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure; D006801:Humans; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000276:immunology / Q000378:metabolism; D015513:Oncogene Proteins / Q000378:metabolism*
D000951:Antigens, Neoplasm; D016213:Cyclins; D019394:Ki-67 Antigen; D015513:Oncogene Proteins; D019938:Cyclin D1